During the past decade, Yale-New Haven Hospital conducted 296 clinical trials. In the 10-year time frame, 296 clinical trials started and 119 clinical trials were completed, i.e. on average, 40.2% percent of trials that started reached the finish line to date. In the past 5 years, 151 clinical trials started and 76 clinical trials were completed. i.e. 50.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Yale-New Haven Hospital" #1 sponsor was "Yale University" with 150 trials, followed by "Abbott Medical Devices" with 14 trials sponsored, "Medtronic Cardiovascular" with 14 trials sponsored, "Pfizer" with 14 trials sponsored and "Vertex Pharmaceuticals Incorporated" with 14 trials sponsored. Other sponsors include 208 different institutions and companies that sponsored additional 152 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Yale-New Haven Hospital" #1 collaborator was "National Institute of Neurological Disorders and Stroke (NINDS)" with 13 trials as a collaborator, "Medical University of South Carolina" with 10 trials as a collaborator, "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 10 trials as a collaborator, "Yale University" with 10 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 9 trials as a collaborator. Other collaborators include 322 different institutions and companies that were collaborators in the rest 218 trials.

According to Clinical.Site data, the most researched conditions in "Yale-New Haven Hospital" are "Heart Failure" (20 trials), "Cystic Fibrosis" (15 trials), "Aortic Valve Stenosis" (8 trials), "Atrial Fibrillation" (8 trials) and "Coronary Artery Disease" (8 trials). Many other conditions were trialed in "Yale-New Haven Hospital" in a lesser frequency.

Most popular intervention types in "Yale-New Haven Hospital" are "Drug" (166 trials), "Device" (121 trials), "Other" (71 trials), "Behavioral" (34 trials) and "Procedure" (31 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (49 trials), "IVA" (7 trials), "Standard of Care" (6 trials), "Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)" (4 trials) and "placebo" (4 trials). Other intervention names were less common.

The vast majority of trials in "Yale-New Haven Hospital" are 380 trials for "All" genders, 33 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are 143 active trials in "Yale-New Haven Hospital". 5 are not yet recruiting, 83 are recruiting, 51 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 196 completed trials in Yale-New Haven Hospital, 1 suspended trials, and 57 terminated clinical trials to date.

Out of the total trials that were conducted in Yale-New Haven Hospital, 30 "Phase 1" clinical trials were conducted, 78 "Phase 2" clinical trials and 75 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 20 trials, and there were also 153 trials that are defined as “Not Applicable".

Yale-New Haven Hospital has several departments that took part in Clinical trials: "Smilow Cancer Hospital Care Center-Trumbull" - 99 trials, "Smilow Cancer Hospital Care Center-Fairfield" - 75 trials, "Smilow Cancer Hospital-Waterbury Care Center" - 73 trials, "Smilow Cancer Center/Yale-New Haven Hospital" - 222 trials, "Smilow Cancer Hospital Care Center at Saint Francis" - 193 trials, "Smilow Cancer Hospital-Derby Care Center" - 72 trials, "Smilow Cancer Hospital-Torrington Care Center" - 68 trials, "Smilow Cancer Hospital Care Center - Guiford" - 66 trials, "Smilow Cancer Hospital-Orange Care Center" - 65 trials, "Yale New Haven Children's Hospital" - 27 trials, "Smilow Cancer Hospital Care Center - Westerly" - 15 trials, "Smilow Cancer Hospital-Hamden Care Center" - 8 trials, "Yale New Haven Hospital - Investigational Drug Services" - 6 trials, "Smilow Cancer Hospital Care Center at North Haven" - 6 trials, "Yale University, Emergency Department" - 5 trials, "Yale New Haven Hosp / Nathan Smith Clinic" - 4 trials, "Yale AIDS Program" - 4 trials, "c/o Thomas Ferencz, RPh, BCOP, Smilow Cancer Hospital at Yale-New Haven" - 3 trials, "Yale New Haven Hospital Research Unit" - 2 trials, "Yale Cardiology" - 2 trials, "Cardiology Associates Of New Haven,Pc" - 2 trials